The estimated Net Worth of Nathaniel Dalton is at least $5.11 million dollars as of 9 December 2021. Mr. Dalton owns over 6,900 units of Icad Inc stock worth over $255,686 and over the last 21 years he sold ICAD stock worth over $4,851,387. In addition, he makes $0 as Independent Director at Icad Inc.
Nathaniel has made over 33 trades of the Icad Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 6,900 units of ICAD stock worth $49,956 on 9 December 2021.
The largest trade he's ever made was exercising 102,702 units of Icad Inc stock on 20 August 2009 worth over $4,346,349. On average, Nathaniel trades about 25,365 units every 96 days since 2003. As of 9 December 2021 he still owns at least 183,947 units of Icad Inc stock.
You can see the complete history of Mr. Dalton stock trades at the bottom of the page.
Nathaniel Dalton J.D. serves as Independent Director of the Company. He is one of the founders of the global asset management firm Affiliated Managers Group, Inc. (NYSE: AMG), where he remains a Director and Senior Advisor. Mr. Dalton held a range of executive positions at AMG, including General Counsel, Chief Operating Officer, President and Chief Executive Officer. He was also the founding investor of Talari Networks, the pioneering SD-WAN technology company, serving as a board observer for more than a decade; and is an investor in, and advisor to, several growth companies operating at the intersection of technology and healthcare. Mr. Dalton is a Trustee of Boston University and serves on the Investment Committee for its Endowment. He also serves on the advisory board of the Institute for Sustainable Energy. Mr. Dalton received a J.D. from Boston University School of Law and a B.A. from the University of Pennsylvania.
Nathaniel Dalton is 53, he's been the Independent Director of Icad Inc since 2020. There are 8 older and 2 younger executives at Icad Inc. The oldest executive at Icad Inc is Michael S. Klein, 67, who is the Exec. Chairman & CEO.
Nathaniel's mailing address filed with the SEC is C/O ICAD INC, 98 SPIT BROOK ROAD SUITE 100, NASHUA, NH, 03062.
Over the last 22 years, insiders at Icad Inc have traded over $10,970,060 worth of Icad Inc stock and bought 704,596 units worth $1,672,448 . The most active insiders traders include Anthony F Ecock, Nathaniel Dalton et Kevin C Burns. On average, Icad Inc executives and independent directors trade stock every 45 days with the average trade being worth of $39,056. The most recent stock trade was executed by Dana R Brown on 31 March 2023, trading 40,000 units of ICAD stock currently worth $52,000.
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Icad Inc executives and other stock owners filed with the SEC include: